New methodology for assessment of intimal hyperplasia of vascular prostheses

ANZ Journal of Surgery

Volumn 72, Issue 9, 2002, Pages 623-627

  Hawthorne, Wayne J ^a,b   Ao, Peng Y ^a   Vicaretti, Mauro ^a   Fletcher, John P ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Gelatin sealed dacron; Intimal hyperplasia; Vascular graft; Vascular prosthesis

Indexed keywords

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; GRAFT PRESERVATION; HYPERPLASIA; IMPLANTATION; INTERMETHOD COMPARISON; INTIMA; MEDICAL ASSESSMENT; METHODOLOGY; NONHUMAN; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; THICKNESS; VASCULAR DISEASE;

ANIMALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HYPERPLASIA; IMAGE PROCESSING, COMPUTER-ASSISTED; POLYETHYLENE TEREPHTHALATES; SHEEP; TUNICA INTIMA;

EID: 0036378324     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2002.t01-1-02506.x     Document Type: Article

References (14)

1. Quinones-Baldrich WJ. Myointimal Hyperplasia: the Lesion. In: Quinones-Baldrich WJ (ed). Pharmacological suppression of intimal hyperplasia 1st edn. Austin: R. G. Landes Company, 1993; 1-10.
2. Chervu A, Moore WS. An overview of intimal hyperplasia. Surg. Gynaecol. Obstet. 1990; 171: 433-46.
3. el-Sanadiki MN, Cross KS, Murray JJ et al. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. Ann. Surg. 1990; 212: 87-96.
4. O'Donohoe MK, Schwartz LB, Radic ZS, Mikat EM, McCann RL, Hagen PO. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann. Surg. 1991; 214: 727-32.
5. Massey MF, Davies MG, Svendsen E et al. Reduction of experimental vein graft intimal hyperplasia by ketanserine. J. Surg. Res. 1993; 54: 30-8.
6. Ao PY, Hawthorne WJ, Taylor DA, Fletcher JP. Optimal dose and duration of heparin for inhibition of intimal hyperplasia. Int. Angiol. 1997; 16: 94-100.
7. Ao PY, Hawthorne WJ, Coombs R, Fletcher JP. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model. Int. Angiol. 1998; 18: 131-9.
8. NH&MRC. Australian code of practice for the care and use of animals for scientific purposes 6th edn. Canberra: Australian Government Publishing Services, 1997.
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8: 307-10.
10. Zacharias RK, Kirkman TR, Clowes AW. Mechanisms of healing in synthetic grafts. J. Vasc. Surg. 1987; 6: 429-36.
11. Greisler HP, Dennis JW, Endean ED, Ellinger J, Buttle KF, Kim DU. Derivation of neointima in vascular grafts. Circulation 1988; 78: I6-12.
12. Clowes AW, Clowes MM, Vergel SC et al. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia. Hypertension 1991; 18: S65-9.
13. Guyotat J, Pelissou-Guyotat I, Lievre M, Chignier E. Inhibition of subintimal hyperplasia of autologous vein bypass grafts by nimodipine in rats: a placebo-controlled study. Neurosurgery 1991; 29: 850-5.
14. Wilson NV, Salisbury JR, Kakkar VV. Effect of low molecular weight heparin on intimal hyperplasia. Br. Surg. 1991; 78: 1381-3.